메뉴 건너뛰기




Volumn 29, Issue 6, 2006, Pages 148-149

New drugs for old

Author keywords

Evergreening; Patent; Perindopril

Indexed keywords

CITALOPRAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESCITALOPRAM; ESOMEPRAZOLE; GENERIC DRUG; OMEPRAZOLE; PERINDOPRIL; PERINDOPRIL ARGININE; PERINDOPRIL ERBUMIN; UNCLASSIFIED DRUG; ZOLPIDEM;

EID: 33845867119     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2006.088     Document Type: Editorial
Times cited : (3)

References (4)
  • 1
    • 85039141308 scopus 로고    scopus 로고
    • Harris G. Prilosec's maker switches users to nexium, thwarting generics. The Wall Street Journal 2002 Jun 7. In: Myhr K. Evergreening of patents. http://www.essentialdrugs.org/edrug/archive/200206/msg00014.php [cited 2006 Nov 8]
    • Harris G. Prilosec's maker switches users to nexium, thwarting generics. The Wall Street Journal 2002 Jun 7. In: Myhr K. Evergreening of patents. http://www.essentialdrugs.org/edrug/archive/200206/msg00014.php [cited 2006 Nov 8]
  • 2
    • 1942489016 scopus 로고    scopus 로고
    • Inside the isomers: The tale of chiral switches
    • Somogyi A, Bochner F, Foster D. Inside the isomers: the tale of chiral switches. Aust Prescr 2004;27:47-9.
    • (2004) Aust Prescr , vol.27 , pp. 47-49
    • Somogyi, A.1    Bochner, F.2    Foster, D.3
  • 3
    • 85039143873 scopus 로고    scopus 로고
    • Swap strategy works for Coversyl. Pharma in Focus 2006 Sep 11. http://www.pharmainfocus.com.au [cited 2006 Sep 11]
    • Swap strategy works for Coversyl. Pharma in Focus 2006 Sep 11. http://www.pharmainfocus.com.au [cited 2006 Sep 11]
  • 4
    • 0042330455 scopus 로고    scopus 로고
    • The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease investigators. Efficacy of perindopril in reduction of cardiac events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial the EUROPA study, Lancet 2003;362:782-8
    • The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease investigators. Efficacy of perindopril in reduction of cardiac events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-8.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.